HARRISON, N.Y. -- Billy Andrade was named this week’s AstraZeneca Charity Challenge winner for his first-place standing entering the final round of the Barclays Classic. The AstraZeneca Charity Challenge, formerly known as the CRESTOR® Charity Challenge, is a season-long competition that recognizes and rewards the tournament leader entering the final round at 35 PGA TOUR events. Through the sponsorship, AstraZeneca will donate $3.5 million this year to designated health care charities and will have donated a three-year total of $9.7 million by the conclusion of the 2006 PGA TOUR season.

For Andrade’s performance, AstraZeneca will donate $50,000 each to the Crohn’s & Colitis Foundation of America (CCFA) and the American College of Physicians Foundation (ACP Foundation) on behalf of Andrade and the Barclays Classic.

“The Crohn’s & Colitis Foundation of America is honored and grateful to receive this donation from the 2006 AstraZeneca Charity Challenge,” says Richard J. Geswell, CCFA President. “This generous contribution will help us to ease the suffering of the 1.4 million Crohn’s and colitis patients in this country. It’s vital funding for the education and support programs our patients rely on, and for the search for a cure for these terrible diseases.”

“The American College of Physicians Foundation is pleased to receive this gift from the AstraZeneca Charity Challenge,” said Jean A. Krause, Executive Vice President and Chief Executive Officer, ACP Foundation. “We will use the donation to support our work to improve the health of patients through initiatives that provide patients with the information they need to understand and manage their health. AstraZeneca's generosity will help us to continue to address the needs of patients with low health literacy.”

AstraZeneca produces a wide range of products that make significant contributions to treatment options and patient care including CRESTOR, NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year’s sponsorship, as part of its commitment to patient health and well being, AstraZeneca will also designate health care related charities across therapeutic areas as recipients at the 35 PGA TOUR events throughout the year.

“AstraZeneca’s partnership with the PGA TOUR is an integral part of our mission of giving back in local communities throughout America,” said Tony Zook, CEO, AstraZeneca U.S. “The AstraZeneca Charity Challenge offers a unique platform for providing important disease awareness, health information and education to make a difference in the lives of patients and consumers everyday.”

The AstraZeneca Charity Challenge is the centerpiece of a multi-year PGA TOUR partnership with AstraZeneca (NYSE:AZN). Last year, AstraZeneca donated $3.5 million through the program. Highlights from the AZCC include:
•Last week, the AstraZeneca Charity Challenge winner at the Memorial Tournament was Carl Pettersson.

• At 17 of the first 20 tournaments of 2006, the AstraZeneca Charity Challenge winner or co-winner went on to win the tournament.

• More than 95 charities have benefited from the program.

• Vijay Singh leads all players with eight AstraZeneca Charity Challenge wins. With some of his charitable “winnings,” Singh donated money to the American Red Cross Hurricane Relief Funds in Florida and New Orleans.

• Other multiple winners have included Jim Furyk, Tom Lehman, Phil Mickelson and Rod Pampling (four), Carl Pettersson, Chad Campbell, Luke Donald, Sergio Garcia, Adam Scott and David Toms (three), and the following players who triumphed twice: Stuart Appleby, Bart Bryant, Chris DiMarco, Tim Herron, Arron Oberholser, Joe Ogilvie, Tom Pernice, Jr., Kenny Perry, Ted Purdy and Tiger Woods.

Fans can log on to www.astrazeneca.pgatour.com to read about past AstraZeneca Charity Challenge winners and learn more about AstraZeneca.

About Crohn's & Colitis Foundation of America
The Crohn's & Colitis Foundation of America's (CCFA) mission is to cure and prevent Crohn's disease and ulcerative colitis through research, and to improve the quality of life of children and adults affected by these digestive diseases through education and support.

About The American College of Physicians Foundation
The American College of Physicians Foundation (ACP Foundation), a nonprofit organization based in Philadelphia, has emerged as an organization on the forefront of identifying and addressing the problems associated with poor health communication, particularly the problems of low health literacy. Through its series of health communication conferences, HEALTH TiPS© for patients, Prescription Bottle Labeling Project, and other programs, the ACP Foundation works to improve the health of the public by increasing patients ability to obtain, process, and understand basic health information needed to make appropriate decisions that affect their health.

About AstraZeneca
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world’s leading pharmaceutical companies with healthcare sales of over $21.4 billion and leading positions in sales of gastrointestinal, cardiovascular, respiratory, oncology and neuroscience products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index. Worldwide, AstraZeneca has six major research and development sites, four discovery facilities and a clinical research site. In total, AstraZeneca’s R&D organization is comprised of more 11,500 people located in seven countries including Canada, France, India, Japan, Sweden, United Kingdom and the United States.